High Eg5 Expression Predicts Poor Prognosis in Breast Cancer

Qin Jin,Fang Huang,Xudong Wang,Huijun Zhu,Yun Xian,Jieying Li,Shu Zhang,Qichao Ni
DOI: https://doi.org/10.18632/oncotarget.19215
2017-01-01
Oncotarget
Abstract:Eg5 is a motor protein belonging to the kinesin-5 family and has been suggested to exert important function in tumors.In this study, we determined the mRNA and protein expression levels of Eg5 in cancerous and non-cancerous breast tissue by quantitative real-time polymerase chain reaction (qRT-PCR) and tissue microarray immunohistochemistry analysis (TMA-IHC) respectively.The results of 20 freshfrozen BC samples demonstrated that Eg5 mRNA levels were significantly higher in BC tissues compared with corresponding non-cancerous tissue (p = 0.0009).TMA-IHC analysis in 127 BC tissues revealed that Eg5 expression obviously correlated with clinicopathologial parameters, including tumor grade (p = 0.004), ER status (p = 0.030), Ki67 status (p = 0.005), molecular classification (p = 0.026), N stage (p = 0.015), and TNM stage (p = 0.001).Kaplan-Meier survival curve indicated that high Eg5 expression (p = 0.012), Ki67 status (p = 0.014) and TNM stage (p = 0.026) were independent factors to predict poor prognosis for patients with breast cancer.Our data suggest that Eg5 is not only overexpressed in BC, it may be also served as a potential prognostic marker.
What problem does this paper attempt to address?